BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
8.81
+0.14 (1.61%)
May 1, 2025, 4:00 PM EDT - Market closed
Company Description
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally.
It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases.
The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
BrainsWay Ltd.
| Country | Israel |
| Founded | 2003 |
| IPO Date | Apr 17, 2019 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 120 |
| CEO | Hadar Levy |
Contact Details
Address: 16 Hartum St, Har Hotzvim Jerusalem, 9777516 Israel | |
| Phone | 972 2 582 4030 |
| Website | brainsway.com |
Stock Details
| Ticker Symbol | BWAY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $11.00 |
| CIK Code | 0001076643 |
| CUSIP Number | 10501L106 |
| ISIN Number | US10501L1061 |
| Employer ID | 04-3285165 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Hadar Levy | Chief Executive Officer |
| Dr. David Zacut M.D. | Co-Founder and Vice-Chairman |
| Avner Hagai | Founder and Director |
| Prof. Abraham Zangen Ph.D. | Co-Founder, Member of Scientific Advisory Board and Director |
| Ido Marom | Chief Financial Officer |
| Ross Mitchell | Vice President of Global Marketing |
| Michael Cohen | Vice President of US Sales |
| Dr. Yiftach Roth Ph.D. | Founder and Chief Scientific Officer |
| Dor Hagai | Vice President of Operations |
| Gilead Moiseyev Ph.D. | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 10, 2010 | REVOKED | Filing |
| Sep 10, 2001 | 4 | Statement of changes in beneficial ownership of securities |
| Sep 5, 2001 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Sep 5, 2001 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Sep 5, 2001 | 8-K | Current Report |
| Aug 15, 2001 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 8, 2001 | 4 | Statement of changes in beneficial ownership of securities |
| Aug 8, 2001 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jul 5, 2001 | 10-K | Annual Report |
| Jun 27, 2001 | 8-K | Current Report |